News
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
The consolidated loss incurred Rs.10508 Lakhs are mainly due to clinical development expenditure incurred by Suven Neurosciences, Inc., on various molecules in the clinical development programs.
Our aim is to provide executives, R&D, clinical development and supply chain, and science marketers from pharma and biopharma companies an independent snapshot of articles and other media, our ...
If you’re after more fun from your city car, plus all-terrain usability, the Panda 4x4 is the one to go for, with its increased ride height, bright skidplates and chunky styling. The 4x4 rides ...
US-based pharmaceutical company Eli Lilly on Thursday announced that its experimental oral GLP-1 pill, named orforglipron, demonstrated statistically significant efficacy results by registering weight ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Suven Pharma Limited (Suven) is a CDMO (contract development and manufacturing organisation) specialising in NCE (new chemical entity) development, providing end-to-end solutions from custom synthesis ...
Australian electric vehicle (EV) distributor AusEV has unveiled what it describes as Australia’s first fully electric 4×4 mining and construction ute, and which it says will beat its fossil fuel ...
The model spied overseas resembled the larger Defender very closely – it had the same upright stance and squared-off proportions but was visibly smaller and low-slung. It will also be an all ...
In addition to its larger screen size, the new infotainment system runs in-house Nissan software, as well as embedded satellite navigation – replacing 'iGo Street' navigation and the Hema 4x4 ...
The global pharmaceuticals market is set to reach US$2.3trn (trillion) by 2028, increasing at a CAGR (compound annual growth rate) of 6%-9%, exceeding earlier ...
all of them hoping to graft old-school 4x4 sensibilities onto new-school platforms. So while ‘groundbreaking innovation’ may well be among MG’s talking points, aesthetically the X is leaning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results